{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:53:50Z","timestamp":1692320030087},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The precise role of pre-mRNA processing factors (PRPs) in human tumorigenesis has not been yet explored. The object of the present study was to explore the effects of PRP3 in a common metastatic skin cancer, keratinocyte-derived cutaneous squamous cell carcinoma (cSCCs). RT-qPCR and western blotting were conducted to measure the expression levels of PRP3 in various cSCC cell lines and cSCC tissues. A benign epidermal keratinocyte cell line was transfected with a eukaryotic expression plasmid to overexpress PRP3. In addition, the endogenous expression level of PRP3 in cSCC cells was silenced using a short hairpin RNA method, and the role of PRP3 on cell proliferation and migration was examined by Cell Counting Kit-8, colony formation, wound healing assay and Transwell assays following knockdown in cSCC cells, and overexpression in keratinovcyte cells. Elevated levels of PRP3 mRNA and protein were noted in cSCC cell lines or cSCC tissues compared with actinic keratosis (AK) or benign epidermal keratinocyte cell line, respectively. Upregulation of PRP3 expression was found to be associated with poor clinical outcomes in patients with cSCCs. The upregulation of PRP3 promoted cell viability, metastasis and the activity of the JAK2\/STAT3 pathway in epidermal keratinocyte cells. Interestingly, loss of PRP3 had no obvious impact on cell viability and migration in benign epidermal keratinocyte cells. Functionally, the inhibition of the JAK2\/STAT3 pathway reversed the increased cell viability and migration of cSCC cells induced by PRP3. Taken together, the present observations indicated that PRP3 served as a tumor active factor in cSCCs by targeting the JAK2\/STAT3 pathway. Moreover, it is implied that impeding the PRP3 activity may selectively constrain cancer cell growth and migration with limited effect on normal skin cells.<\/jats:p>","DOI":"10.1038\/s41598-020-65928-8","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T10:03:14Z","timestamp":1591005794000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2\/STAT3 pathway"],"prefix":"10.1038","volume":"10","author":[{"given":"Siyao","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanguo","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"65928_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev-biochem-060614-034242","volume":"84","author":"S Naftelberg","year":"2015","unstructured":"Naftelberg, S., Schor, I. E., Ast, G. & Kornblihtt, A. R. Regulation of alternative splicing through coupling with transcription and chromatin structure. Annual review of biochemistry 84, 165\u2013198, https:\/\/doi.org\/10.1146\/annurev-biochem-060614-034242 (2015).","journal-title":"Annual review of biochemistry"},{"key":"65928_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1261\/rna.058065.116","volume":"23","author":"R Yoshimoto","year":"2017","unstructured":"Yoshimoto, R. et al. Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A. Rna 23, 47\u201357, https:\/\/doi.org\/10.1261\/rna.058065.116 (2017).","journal-title":"Rna"},{"key":"65928_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrm.2017.86","volume":"18","author":"Y Shi","year":"2017","unstructured":"Shi, Y. Mechanistic insights into precursor messenger RNA splicing by the spliceosome. Nature reviews. Molecular cell biology 18, 655\u2013670, https:\/\/doi.org\/10.1038\/nrm.2017.86 (2017).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"65928_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajhg.2017.11.002","volume":"102","author":"E Park","year":"2018","unstructured":"Park, E., Pan, Z., Zhang, Z., Lin, L. & Xing, Y. The Expanding Landscape of Alternative Splicing Variation in Human Populations. American journal of human genetics 102, 11\u201326, https:\/\/doi.org\/10.1016\/j.ajhg.2017.11.002 (2018).","journal-title":"American journal of human genetics"},{"key":"65928_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1101\/gad.311043.117","volume":"32","author":"LI Finci","year":"2018","unstructured":"Finci, L. I. et al. The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action. Genes & development 32, 309\u2013320, https:\/\/doi.org\/10.1101\/gad.311043.117 (2018).","journal-title":"Genes & development"},{"key":"65928_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee, S. C. & Abdel-Wahab, O. Therapeutic targeting of splicing in cancer. Nature medicine 22, 976\u2013986, https:\/\/doi.org\/10.1038\/nm.4165 (2016).","journal-title":"Nature medicine"},{"issue":"2","key":"65928_CR7","doi-asserted-by":"publisher","first-page":"e1381","DOI":"10.1002\/wrna.1381","volume":"8","author":"Kerstin A. Effenberger","year":"2016","unstructured":"Effenberger, K. A., Urabe, V. K. & Jurica, M. S. Modulating splicing with small molecular inhibitors of the spliceosome. Wiley interdisciplinary reviews. RNA 8, https:\/\/doi.org\/10.1002\/wrna.1381 (2017).","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"key":"65928_CR8","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1126\/science.aac7629","volume":"349","author":"C Yan","year":"2015","unstructured":"Yan, C. et al. Structure of a yeast spliceosome at 3.6-angstrom resolution. Science 349, 1182\u20131191, https:\/\/doi.org\/10.1126\/science.aac7629 (2015).","journal-title":"Science"},{"key":"65928_CR9","doi-asserted-by":"publisher","first-page":"18113","DOI":"10.1074\/jbc.M117.797357","volume":"292","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. Identification of a 35S U4\/U6.U5 tri-small nuclear ribonucleoprotein (tri-snRNP) complex intermediate in spliceosome assembly. The Journal of biological chemistry 292, 18113\u201318128, https:\/\/doi.org\/10.1074\/jbc.M117.797357 (2017).","journal-title":"The Journal of biological chemistry"},{"key":"65928_CR10","doi-asserted-by":"publisher","first-page":"12126","DOI":"10.1093\/nar\/gky966","volume":"46","author":"P Bao","year":"2018","unstructured":"Bao, P., Boon, K. L., Will, C. L., Hartmuth, K. & Luhrmann, R. Multiple RNA-RNA tertiary interactions are dispensable for formation of a functional U2\/U6 RNA catalytic core in the spliceosome. Nucleic acids research 46, 12126\u201312138, https:\/\/doi.org\/10.1093\/nar\/gky966 (2018).","journal-title":"Nucleic acids research"},{"key":"65928_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-biophys-070317-033410","volume":"47","author":"ME Wilkinson","year":"2018","unstructured":"Wilkinson, M. E., Lin, P. C., Plaschka, C. & Nagai, K. Cryo-EM Studies of Pre-mRNA Splicing: From Sample Preparation to Model Visualization. Annual review of biophysics 47, 175\u2013199, https:\/\/doi.org\/10.1146\/annurev-biophys-070317-033410 (2018).","journal-title":"Annual review of biophysics"},{"key":"65928_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg.2015.3","volume":"17","author":"MM Scotti","year":"2016","unstructured":"Scotti, M. M. & Swanson, M. S. RNA mis-splicing in disease. Nature reviews. Genetics 17, 19\u201332, https:\/\/doi.org\/10.1038\/nrg.2015.3 (2016).","journal-title":"Nature reviews. Genetics"},{"issue":"10","key":"65928_CR13","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.3390\/ijms20102542","volume":"20","author":"Michalitsa Diakatou","year":"2019","unstructured":"Diakatou, M., Manes, G., Bocquet, B., Meunier, I. & Kalatzis, V. Genome Editing as a Treatment for the Most Prevalent Causative Genes of Autosomal Dominant Retinitis Pigmentosa. International journal of molecular sciences 20, https:\/\/doi.org\/10.3390\/ijms20102542 (2019).","journal-title":"International Journal of Molecular Sciences"},{"key":"65928_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcdb.2017.10.011","volume":"79","author":"M Krausova","year":"2018","unstructured":"Krausova, M. & Stanek, D. snRNP proteins in health and disease. Seminars in cell & developmental biology 79, 92\u2013102, https:\/\/doi.org\/10.1016\/j.semcdb.2017.10.011 (2018).","journal-title":"Seminars in cell & developmental biology"},{"key":"65928_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tig.2017.12.012","volume":"34","author":"KT Carey","year":"2018","unstructured":"Carey, K. T. & Wickramasinghe, V. O. Regulatory Potential of the RNA Processing Machinery: Implications for Human Disease. Trends in genetics: TIG 34, 279\u2013290, https:\/\/doi.org\/10.1016\/j.tig.2017.12.012 (2018).","journal-title":"Trends in genetics: TIG"},{"key":"65928_CR16","doi-asserted-by":"publisher","first-page":"e12817","DOI":"10.1111\/acel.12817","volume":"17","author":"R Stegeman","year":"2018","unstructured":"Stegeman, R., Hall, H., Escobedo, S. E., Chang, H. C. & Weake, V. M. Proper splicing contributes to visual function in the aging Drosophila eye. Aging cell 17, e12817, https:\/\/doi.org\/10.1111\/acel.12817 (2018).","journal-title":"Aging cell"},{"key":"65928_CR17","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/onc.2015.318","volume":"35","author":"A Sveen","year":"2016","unstructured":"Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A. & Skotheim, R. I. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35, 2413\u20132427, https:\/\/doi.org\/10.1038\/onc.2015.318 (2016).","journal-title":"Oncogene"},{"key":"65928_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas, A., Leonardi-Bee, J. & Bath-Hextall, F. A systematic review of worldwide incidence of nonmelanoma skin cancer. The British journal of dermatology 166, 1069\u20131080, https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10830.x (2012).","journal-title":"The British journal of dermatology"},{"key":"65928_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","volume":"29","author":"R Gordon","year":"2013","unstructured":"Gordon, R. Skin cancer: an overview of epidemiology and risk factors. Seminars in oncology nursing 29, 160\u2013169, https:\/\/doi.org\/10.1016\/j.soncn.2013.06.002 (2013).","journal-title":"Seminars in oncology nursing"},{"key":"65928_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu, H., Lee, H., Herrmann, A., Buettner, R. & Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nature reviews. Cancer 14, 736\u2013746, https:\/\/doi.org\/10.1038\/nrc3818 (2014).","journal-title":"Nature reviews. Cancer"},{"key":"65928_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1261-y","volume":"10","author":"D Hao","year":"2019","unstructured":"Hao, D. et al. Sanshool improves UVB-induced skin photodamage by targeting JAK2\/STAT3-dependent autophagy. Cell Death and Disease 10, 19 (2019).","journal-title":"Cell Death and Disease"},{"key":"65928_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0600-4","volume":"32","author":"X Zhang","year":"2015","unstructured":"Zhang, X., Ruan, Y., Li, Y., Lin, D. & Quan, C. Tight junction protein claudin-6 inhibits growth and induces the apoptosis of cervical carcinoma cells in vitro and in vivo. Medical oncology 32, 148, https:\/\/doi.org\/10.1007\/s12032-015-0600-4 (2015).","journal-title":"Medical oncology"},{"key":"65928_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12079-019-00509-7","volume":"13","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. CLDN10 promotes a malignant phenotype of osteosarcoma cells via JAK1\/Stat1 signaling. Journal of cell communication and signaling 13, 395\u2013405, https:\/\/doi.org\/10.1007\/s12079-019-00509-7 (2019).","journal-title":"Journal of cell communication and signaling"},{"key":"65928_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0662-4","volume":"18","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Wang, H., Li, Q. & Li, T. CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin\/ERK signaling pathway. Cancer cell international 18, 160, https:\/\/doi.org\/10.1186\/s12935-018-0662-4 (2018).","journal-title":"Cancer cell international"},{"key":"65928_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1096\/fj.14-257550","volume":"29","author":"G Niu","year":"2015","unstructured":"Niu, G. et al. Orphan nuclear receptor TR3\/Nur77 improves wound healing by upregulating the expression of integrin beta4. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 131\u2013140, https:\/\/doi.org\/10.1096\/fj.14-257550 (2015).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"65928_CR26","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00439-017-1790-y","volume":"136","author":"LM Gallego-Paez","year":"2017","unstructured":"Gallego-Paez, L. M. et al. Alternative splicing: the pledge, the turn, and the prestige: The key role of alternative splicing in human biological systems. Human genetics 136, 1015\u20131042, https:\/\/doi.org\/10.1007\/s00439-017-1790-y (2017).","journal-title":"Human genetics"},{"key":"65928_CR27","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41418-018-0231-3","volume":"26","author":"C Di","year":"2019","unstructured":"Di, C. et al. Function, clinical application, and strategies of Pre-mRNA splicing in cancer. Cell death and differentiation 26, 1181\u20131194, https:\/\/doi.org\/10.1038\/s41418-018-0231-3 (2019).","journal-title":"Cell death and differentiation"},{"key":"65928_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/gcc.22784","volume":"58","author":"J Taylor","year":"2019","unstructured":"Taylor, J. & Lee, S. C. Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies. Genes, chromosomes & cancer 58, 889\u2013902, https:\/\/doi.org\/10.1002\/gcc.22784 (2019).","journal-title":"Genes, chromosomes & cancer"},{"issue":"11","key":"65928_CR29","doi-asserted-by":"publisher","first-page":"a032417","DOI":"10.1101\/cshperspect.a032417","volume":"11","author":"Berthold Kastner","year":"2019","unstructured":"Kastner, B., Will, C. L., Stark, H. & Luhrmann, R. Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes. Cold Spring Harbor perspectives in biology 11, https:\/\/doi.org\/10.1101\/cshperspect.a032417 (2019).","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"65928_CR30","doi-asserted-by":"publisher","first-page":"e13053","DOI":"10.1111\/apha.13053","volume":"222","author":"V Schmidt","year":"2018","unstructured":"Schmidt, V. & Kirschner, K. M. Alternative pre-mRNA splicing. Acta physiologica 222, e13053, https:\/\/doi.org\/10.1111\/apha.13053 (2018).","journal-title":"Acta physiologica"},{"key":"65928_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey, A. L., Edrada-Ebel, R. & Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era. Nature reviews. Drug discovery 14, 111\u2013129, https:\/\/doi.org\/10.1038\/nrd4510 (2015).","journal-title":"Nature reviews. Drug discovery"},{"key":"65928_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","volume":"139","author":"M Diaz-Coranguez","year":"2017","unstructured":"Diaz-Coranguez, M., Ramos, C. & Antonetti, D. A. The inner blood-retinal barrier: Cellular basis and development. Vision research 139, 123\u2013137, https:\/\/doi.org\/10.1016\/j.visres.2017.05.009 (2017).","journal-title":"Vision research"},{"key":"65928_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.gde.2017.10.010","volume":"48","author":"AA Agrawal","year":"2018","unstructured":"Agrawal, A. A., Yu, L., Smith, P. G. & Buonamici, S. Targeting splicing abnormalities in cancer. Current opinion in genetics & development 48, 67\u201374, https:\/\/doi.org\/10.1016\/j.gde.2017.10.010 (2018).","journal-title":"Current opinion in genetics & development"},{"issue":"1","key":"65928_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms19010075","volume":"19","author":"Jung-Chun Lin","year":"2017","unstructured":"Lin, J. C. Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment. International journal of molecular sciences 19, https:\/\/doi.org\/10.3390\/ijms19010075 (2017).","journal-title":"International Journal of Molecular Sciences"},{"key":"65928_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.seminhematol.2017.06.007","volume":"54","author":"YJ Kim","year":"2017","unstructured":"Kim, Y. J. & Abdel-Wahab, O. Therapeutic targeting of RNA splicing in myelodysplasia. Seminars in hematology 54, 167\u2013173, https:\/\/doi.org\/10.1053\/j.seminhematol.2017.06.007 (2017).","journal-title":"Seminars in hematology"},{"key":"65928_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2009.05.009","volume":"68","author":"T Li","year":"2010","unstructured":"Li, T. et al. Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naive patients with advanced stage non-small cell lung cancer (NSCLC). Lung cancer 68, 89\u201393, https:\/\/doi.org\/10.1016\/j.lungcan.2009.05.009 (2010).","journal-title":"Lung cancer"},{"key":"65928_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11899-016-0344-z","volume":"11","author":"CK Brierley","year":"2016","unstructured":"Brierley, C. K. & Steensma, D. P. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms. Current hematologic malignancy reports 11, 408\u2013415, https:\/\/doi.org\/10.1007\/s11899-016-0344-z (2016).","journal-title":"Current hematologic malignancy reports"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65928-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65928-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:04:46Z","timestamp":1670328286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65928-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65928"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65928-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8863"}}